Data / Form D filings / Alexza Pharmaceuticals Inc.
Alexza Pharmaceuticals Inc.: Form D filings
Alexza Pharmaceuticals Inc., a pharmaceuticals company in Mountain View, CA, filed 9 Form D notices with the SEC between 2009 and 2016. The latest, on February 24, 2016, reports $5 million sold of a $5 million offering to 1 investor.
Find out what Alexza Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2091 STIERLIN COURT, Mountain View, CA, 94043
- Phone
- (650) 944-7000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1344413
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 24, 2016 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Feb 23, 2016 | sec.gov |
| Sep 28, 2015 | New notice | $143,750 | $143,750 | $0 | 1 | Sep 28, 2015 | sec.gov |
| Oct 28, 2014 | New notice | $8,000,000 | $8,000,000 | $0 | 1 | Oct 27, 2014 | sec.gov |
| Mar 28, 2014 | New notice | $3,457 | $3,457 | $0 | 9 | Mar 18, 2014 | sec.gov |
| May 21, 2013 | New notice | $25,000,000 | $0 | $25,000,000 | 1 | Yet to occur | sec.gov |
| Mar 16, 2012 | New notice | $3,000,000 | $3,000,000 | $0 | 1 | Mar 15, 2012 | sec.gov |
| May 12, 2010 | New notice | $1,012,500 | $1,012,500 | $0 | 1 | May 4, 2010 | sec.gov |
| Oct 6, 2009 | New notice | $19,720,309 | $19,720,309 | $0 | 30 | Oct 5, 2009 | sec.gov |
| Aug 27, 2009 | New notice | Indefinite | $0 | Indefinite | 15 | Aug 26, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Isaac Leighton Stein | Director | |
| Deepika R Pakianathan | Director | |
| Joseph L Turner | Director | |
| Thomas B King | Executive Officer, Director | |
| J Leighton Read | Director | |
| Gordon Leighton Ringold | Director | |
| Edwin S Kamemoto | Executive Officer | |
| J Kevin Buchi | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Feb 22, 2016 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Alexza Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.